CMRA vs. VRPX, SCPS, EVLO, GNCAQ, GNCA, ARDS, CALA, STAB, NMTR, and AMPE
Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Calithera Biosciences (CALA), Statera Biopharma (STAB), 9 Meters Biopharma (NMTR), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "pharmaceutical products" industry.
Comera Life Sciences vs. Its Competitors
Comera Life Sciences (NASDAQ:CMRA) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.
Comera Life Sciences has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500.
In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score.
Comera Life Sciences' return on equity of 0.00% beat Virpax Pharmaceuticals' return on equity.
32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 8.9% of Comera Life Sciences shares are held by insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Virpax Pharmaceuticals has lower revenue, but higher earnings than Comera Life Sciences.
Summary
Comera Life Sciences and Virpax Pharmaceuticals tied by winning 4 of the 8 factors compared between the two stocks.
Get Comera Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Comera Life Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:CMRA) was last updated on 8/14/2025 by MarketBeat.com Staff
MarketBeat All Access